1. Home
  2. YMAB vs CFFI Comparison

YMAB vs CFFI Comparison

Compare YMAB & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • CFFI
  • Stock Information
  • Founded
  • YMAB 2015
  • CFFI 1927
  • Country
  • YMAB United States
  • CFFI United States
  • Employees
  • YMAB N/A
  • CFFI 545
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • CFFI Major Banks
  • Sector
  • YMAB Health Care
  • CFFI Finance
  • Exchange
  • YMAB Nasdaq
  • CFFI Nasdaq
  • Market Cap
  • YMAB 192.4M
  • CFFI 205.8M
  • IPO Year
  • YMAB 2018
  • CFFI 1998
  • Fundamental
  • Price
  • YMAB $8.51
  • CFFI $64.85
  • Analyst Decision
  • YMAB Buy
  • CFFI
  • Analyst Count
  • YMAB 11
  • CFFI 0
  • Target Price
  • YMAB $15.02
  • CFFI N/A
  • AVG Volume (30 Days)
  • YMAB 1.3M
  • CFFI 16.3K
  • Earning Date
  • YMAB 08-08-2025
  • CFFI 07-24-2025
  • Dividend Yield
  • YMAB N/A
  • CFFI 2.89%
  • EPS Growth
  • YMAB N/A
  • CFFI 32.37
  • EPS
  • YMAB N/A
  • CFFI 7.57
  • Revenue
  • YMAB $88,658,000.00
  • CFFI $122,075,000.00
  • Revenue This Year
  • YMAB N/A
  • CFFI N/A
  • Revenue Next Year
  • YMAB $15.23
  • CFFI N/A
  • P/E Ratio
  • YMAB N/A
  • CFFI $8.40
  • Revenue Growth
  • YMAB 4.92
  • CFFI 7.42
  • 52 Week Low
  • YMAB $3.55
  • CFFI $50.70
  • 52 Week High
  • YMAB $16.11
  • CFFI $89.90
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.64
  • CFFI 49.37
  • Support Level
  • YMAB $4.16
  • CFFI $62.52
  • Resistance Level
  • YMAB $8.54
  • CFFI $64.94
  • Average True Range (ATR)
  • YMAB 0.24
  • CFFI 1.45
  • MACD
  • YMAB 0.47
  • CFFI -0.27
  • Stochastic Oscillator
  • YMAB 99.32
  • CFFI 41.41

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

Share on Social Networks: